Positive Heparin/PF4 Antibodies and High Mortality Rate: a Retrospective Case-Series Analysis

Ezelsoy M., Saracoglu K. T. , Oral K., Saracoglu A. , Akpinar B.

BRAZILIAN JOURNAL OF CARDIOVASCULAR SURGERY, vol.35, no.6, pp.950-957, 2020 (Journal Indexed in SCI) identifier identifier

  • Publication Type: Article / Article
  • Volume: 35 Issue: 6
  • Publication Date: 2020
  • Doi Number: 10.21470/1678-9741-2019-0360
  • Title of Journal : BRAZILIAN JOURNAL OF CARDIOVASCULAR SURGERY
  • Page Numbers: pp.950-957

Abstract

Introduction: Heparin-induced thrombocytopenia (HIT) is a potentially lethal complication of unfractionated or low-molecular weight heparin therapy. We aimed to determine the incidence and mortality rate of patients with positive heparin/platelet factor 4 (PF4) antibodies, which is a rapid detection test of HIT.